Corticosteroid_NN
receptors_NNS
in_IN
lymphocytes_NNS
:_:
a_DT
possible_JJ
marker_NN
of_IN
brain_NN
involution_NN
?_.

A_DT
similarity_NN
has_VBZ
recently_RB
been_VBN
found_VBN
between_IN
the_DT
regulation_NN
of_IN
corticosteroid_NN
receptors_NNS
in_IN
brain_NN
and_CC
in_IN
lymphoid_JJ
tissue_NN
._.

We_PRP
have_VBP
studied_VBN
the_DT
regulation_NN
of_IN
corticosteroid_NN
receptors_NNS
in_IN
human_JJ
mononuclear_JJ
leukocytes_NNS
as_IN
a_DT
possible_JJ
marker_NN
of_IN
brain_NN
involution_NN
._.

Type_NN
I_CD
corticosteroid_NN
receptors_NNS
are_VBP
down_RB
regulated_VBN
by_IN
excess_NN
of_IN
mineralocorticoids_NNS
-LRB-_-LRB-
primary_JJ
and_CC
secondary_JJ
hyperaldosteronism_NN
,_,
pseudohyperaldosteronism_RB
-RRB-_-RRB-
and_CC
of_IN
glucocorticoids_NNS
-LRB-_-LRB-
Cushing_NN
's_POS
syndrome_NN
-RRB-_-RRB-
._.

Type_NN
II_CD
corticosteroid_NN
receptors_NNS
are_VBP
not_RB
reduced_VBN
by_IN
excess_NN
of_IN
endogenous_JJ
corticosteroids_NNS
-LRB-_-LRB-
Cushing_NN
's_POS
syndrome_NN
-RRB-_-RRB-
._.

In_IN
normal_JJ
adults_NNS
there_EX
is_VBZ
a_DT
direct_JJ
significant_JJ
correlation_NN
between_IN
plasma_NN
cortisol_NN
and_CC
Type_NN
I_NN
and_CC
between_IN
plasma_NN
cortisol_NN
and_CC
Type_NN
II_CD
receptors_NNS
in_IN
mononuclear_JJ
leukocytes_NNS
,_,
while_IN
in_IN
Cushing_NN
's_POS
syndrome_NN
the_DT
correlation_NN
is_VBZ
inverse_JJ
between_IN
plasma_NN
cortisol_NN
at_IN
8_CD
a.m._RB
and_CC
Type_NN
II_CD
receptors_NNS
._.

In_IN
an_DT
aged_JJ
population_NN
the_DT
mean_JJ
numbers_NNS
of_IN
Type_NN
I_NN
and_CC
of_IN
Type_NN
II_CD
receptors_NNS
are_VBP
lower_JJR
and_CC
plasma_NN
cortisol_NN
is_VBZ
higher_JJR
than_IN
in_IN
adult_JJ
controls_NNS
,_,
but_CC
the_DT
increase_NN
of_IN
plasma_NN
cortisol_NN
is_VBZ
not_RB
followed_VBN
by_IN
a_DT
clinical_JJ
picture_NN
of_IN
hypercorticism_NN
._.

Corticosteroid_NN
Type_NN
I_CD
and_CC
Type_NN
II_CD
receptors_NNS
are_VBP
inversely_RB
correlated_VBN
with_IN
age_NN
._.

After_IN
dexamethasone_NN
suppression_NN
-LRB-_-LRB-
1_CD
mg_NN
at_IN
11_CD
p.m._NN
-RRB-_-RRB-
Type_NN
I_NN
receptors_NNS
always_RB
decrease_VBP
in_IN
controls_NNS
while_IN
the_DT
response_NN
of_IN
Type_NN
II_CD
is_VBZ
not_RB
homogeneous_JJ
._.

In_IN
an_DT
aged_JJ
group_NN
of_IN
patients_NNS
,_,
both_DT
receptors_NNS
are_VBP
reduced_VBN
by_IN
dexamethasone_NN
._.

We_PRP
conclude_VBP
that_IN
the_DT
decrease_NN
with_IN
age_NN
of_IN
corticosteroid_NN
receptors_NNS
is_VBZ
possibly_RB
related_JJ
to_TO
a_DT
physiological_JJ
involution_NN
of_IN
corticosteroid_NN
receptors_NNS
and_CC
that_IN
this_DT
reduction_NN
does_VBZ
increase_NN
plasma_NN
cortisol_NN
concentration_NN
,_,
without_IN
affecting_VBG
the_DT
glucocorticoid_NN
effector_NN
mechanism_NN
._.

